Health Catalyst Reports Fourth Quarter and Year End 2020 Results

Go back to Health Catalyst Reports Fourth Quarter and Year End 2020 Results

Health Catalyst (HCAT) Tops Q4 EPS by 3c

February 25, 2021 5:32 PM EST

Health Catalyst (NASDAQ: HCAT) reported Q4 EPS of ($0.16), $0.03 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $53.3 million versus the consensus estimate of $52.12 million.

In the fourth quarter of 2020, I am pleased to share that we achieved strong performance across... More